Doma Perpetual资本管理公司正对Pacira Pharmaceuticals发起积极行动。这家投资机构目前持有Pacira约7.5%的股份，现已公开呼吁公司董事会罢免现任首席执行官，并启动全面的战略评估，以寻求潜在的出售机会。
为推进其主张，Doma Perpetual已提名三位新董事候选人进入Pacira董事会，他们分别是Eric de Armas、Christopher Dennis以及Oliver Benton Curtis III。此举旨在推动公司治理变革，为潜在的战略转型铺平道路。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.